Dorzolamide and Timolol Ophthalmic

Dorzolamide and timolol ophthalmic is used to lower elevated pressure inside the eye (intraocular pressure) in patients who haven't responded well enough to a beta-blocker eye drop on its own.

• Open-angle glaucoma — the most common form of glaucoma, where eye pressure rises and can damage the optic nerve over time
• Ocular hypertension — higher-than-normal eye pressure that raises the risk of glaucoma but hasn't yet caused visible damage
• Cosopt PF (preservative-free formulation) is specifically indicated for the above uses in patients insufficiently responsive to beta-blockers
• The individual components, dorzolamide and timolol, have established safety and effectiveness in children aged 2 and older when used separately; their combined use in adults and children follows these principles

These drops work through two separate but complementary pathways. Dorzolamide blocks an enzyme called carbonic anhydrase II in the eye's ciliary body (the tissue that makes eye fluid). With that enzyme blocked, less aqueous humor — the clear fluid that fills the eye — is produced, and eye pressure drops. Timolol is a non-selective beta-blocker that also reduces aqueous humor production by blocking beta-adrenergic receptors in the same tissue. Together, they lower eye pressure more than either drug alone, which helps protect the optic nerve from damage caused by elevated pressure.

These eye drops are used twice daily — one drop in the affected eye or eyes each time. If you are also using other eye medications, space them at least 5 minutes apart to avoid washing one out before it works.

• Cosopt PF comes in single-use preservative-free vials — open one, use it right away, and discard any leftover solution; don't store opened units
• There are no specific food restrictions with eye drops
• If you miss a dose, use it as soon as you remember, then continue your regular schedule — don't double up
• Always follow your prescriber's specific instructions

The most common side effects affect your eyes or your sense of taste right after using the drops.

• Bitter, sour, or unusual taste in the mouth (up to 30% of users)
• Burning or stinging in the eye (up to 30% of users)
• Eye redness (conjunctival hyperemia)
• Blurred or cloudy vision
• Eye itching
• Superficial punctate keratitis (tiny irritation spots on the corneal surface)
• Eye discharge, tearing, or foreign body sensation
• Headache or dizziness

Serious reactions — including breathing problems, signs of heart failure, or severe skin reactions such as blistering or peeling rash — require immediate medical attention. Stop using the drops and contact your doctor or emergency services right away if any of these occur.

• Breathing problems: Timolol is absorbed into the bloodstream even from the eye. It can trigger severe bronchospasm or respiratory failure in people with asthma or COPD — this medication is contraindicated in those patients. Even patients with milder lung disease should generally avoid it.
• Heart risks: Timolol can worsen heart failure or cause dangerously slow heart rate or heart block. Stop the drops and get immediate help if you develop signs of heart failure. People with sinus bradycardia, heart block, overt cardiac failure, or cardiogenic shock must not use this medication.
• Sulfonamide reactions: Dorzolamide is a sulfonamide. Even as an eye drop, it can trigger rare but life-threatening reactions including Stevens-Johnson syndrome (a severe skin-blistering condition), toxic epidermal necrolysis, liver failure, and serious blood disorders. Any sign of a severe systemic reaction means stop the drops immediately.
• Masking of low blood sugar: Timolol can hide the racing heartbeat that normally warns you of hypoglycemia. Diabetic patients — especially those on insulin — need to be extra vigilant.
• Masking of thyroid problems: Timolol can hide the fast heart rate that signals an overactive thyroid (thyrotoxicosis). Don't stop the drops abruptly if thyroid disease is suspected, as this could trigger a thyroid storm.
• Allergen sensitivity: If you have a history of severe allergic reactions, beta-blockers may make you less responsive to standard epinephrine (adrenaline) used to treat anaphylaxis.

Because timolol and dorzolamide enter the bloodstream from the eye, they can interact with several other medications.

• Oral carbonic anhydrase inhibitors (e.g., acetazolamide): not recommended together — doubles up on the same mechanism and increases the risk of systemic side effects
• Oral or topical beta-blockers: additive beta-blocking effects on heart rate and eye pressure; two topical beta-blockers should not be used together
• Calcium channel blockers (e.g., verapamil, diltiazem): can cause heart rhythm disturbances, low blood pressure, or worsening heart function, especially in patients with cardiac problems
• Digoxin combined with calcium channel blockers: may further slow electrical conduction through the heart
• Catecholamine-depleting drugs (e.g., reserpine): can cause severe low blood pressure or very slow heart rate, leading to dizziness or fainting
• CYP2D6 inhibitors (e.g., quinidine, certain SSRIs like fluoxetine): raise timolol blood levels, intensifying beta-blocking effects including slowed heart rate and mood effects
• High-dose salicylates (e.g., high-dose aspirin): possible acid-base or electrolyte disturbances when combined with dorzolamide
• Clonidine: stopping clonidine while using a beta-blocker may cause rebound high blood pressure

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

• Do not use if you have asthma, a history of asthma, or severe COPD — this is an absolute contraindication
• Do not use if you have sinus bradycardia, second- or third-degree heart block, overt heart failure, or cardiogenic shock
• Do not use if you are allergic to any component, including sulfonamide-type drugs
• Tell your doctor if you have mild or moderate COPD, emphysema, or any bronchospastic condition — beta-blockers should generally be avoided in these situations
• Tell your doctor if you have diabetes — timolol can mask hypoglycemia symptoms
• Tell your doctor if you have a thyroid condition — timolol can hide signs of an overactive thyroid
• Tell your doctor if you have kidney disease — dorzolamide has not been studied in severe kidney impairment and is not recommended in that setting; mild-to-moderate kidney disease warrants caution
• Tell your doctor if you have liver disease — dorzolamide has not been studied in patients with severe hepatic impairment
• Pregnancy: No adequate studies in pregnant women; animal studies showed some fetal effects at high doses. Discuss the risks and benefits with your doctor.
• Breastfeeding: It is not known if these drugs pass into breast milk. Discuss with your doctor before using while nursing.
• Children under 2 years: Safety and effectiveness have not been established in this age group
• Older adults: No overall differences in safety or effectiveness have been observed compared to younger patients
• Tell your surgeon or anesthesiologist you use these drops before any procedure — timolol can interfere with reflexes during surgery

If too much of this medication enters the body — whether from the eye drops or accidentally — symptoms may include slow heart rate (bradycardia), bronchospasm (airway tightening), shortness of breath, dizziness, headache, electrolyte imbalances, abnormal blood pH, and in severe cases, cardiac arrest or effects on the central nervous system. If an overdose is suspected, seek emergency medical care right away. The label notes that timolol does not clear the body easily through dialysis.

Both dorzolamide and timolol work by reducing the production of aqueous humor — the fluid inside the eye — which directly lowers intraocular pressure (IOP). High IOP is the main risk factor for optic nerve damage and progressive vision loss in glaucoma. Using both agents together lowers IOP more than either drug alone. The combined twice-daily regimen produces a meaningful reduction in eye pressure, though it is slightly less than what is achieved when each drug is used at its maximum separate frequency.

Even though these are eye drops, both ingredients are absorbed into the bloodstream. Dorzolamide accumulates in red blood cells over time; its breakdown product is excreted in the urine. After stopping dorzolamide, it clears from red blood cells slowly — with a late-phase half-life of about four months. Timolol is also absorbed systemically from the eye; peak blood levels after a morning dose are very low but measurable. These systemic levels are enough to cause drug interactions and side effects typical of oral beta-blockers and sulfonamides, which is why careful patient selection matters.

Store Dorzolamide hydrochloride and Timolol maleate Ophthalmic Solution, USP (preservative free) at 20° to 25°C (68° to 77°F) . Do not freeze. Store in the original pouch.